Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM463478 (3-(4-(N-Methylmethan-3-ylsulfonamido)piperidin-1-y...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2D79FN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM463505 (3-(4-(Methylsulfonyl)piperazin-1-yl)-2-phenylquino...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2D79FN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM463506 (3-(4-(N-Methylacetamido)piperidin-1-yl)-2-phenylqu...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2D79FN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM574805 (3-(4-(Methyl(phenyl)amino)piperidin-1-yl)-2-phenyl...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2D79FN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM574806 (3-(Diethylamino)-2-phenylquinoxaline-6-carboxylic ...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2D79FN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM463509 (3-(4-Acetamidopiperidin-1-yl)-2-phenylquinoxaline-...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2D79FN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM463510 (3-(N-Methylmethan-5-ylsulfonamido)-2-phenylquinoxa...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2D79FN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM463511 (3-(3,4-Dihydroisoquinolin-2(1H)-yl)-2-phenylquinox...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2D79FN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM463479 (3-(3,4-Dihydroquinolin-1(2H)-yl)-2-phenylquinoxali...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2D79FN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM463512 (3-(Phenethylamino)-2-phenylquinoxaline-6-carboxyli...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2D79FN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM463513 (3-(Methyl(phenethyl)amino)-2-phenylquinoxaline-6-c...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2D79FN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM463480 (3-(Isopropyl(methyl)amino)-2-phenylquinoxaline-6-c...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2D79FN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM463514 (3-(Cyclohexylamino)-2-phenylquinoxaline-6-carboxyl...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2D79FN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM463515 (3-(2-Methylpiperidin-1-yl)-2-phenylquinoxaline-6-c...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2D79FN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM463481 (3-(Cyclopropyl(methyl)amino)-2-phenylquinoxaline-6...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2D79FN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM463516 (3-(2-Methylpyrrolidin-1-yl)-2-phenylquinoxaline-6-...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2D79FN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM463517 (US10781185, Example 48 | US11459307, Example 48) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2D79FN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM463518 ((R)-3-(3-Hydroxypyrrolidin-1-yl)-2-phenylquinoxali...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2D79FN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM463519 ((S)-3-(3-Hydroxypyrrolidin-1-yl)-2-phenylquinoxali...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2D79FN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM463482 ((R)-3-(2-(Methoxymethyl)pyrrolidin-1-yl)-2-phenylq...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2D79FN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM463483 ((R)-3-(2-(Hydroxymethyl)pyrrolidin-1-yl)-2-phenylq...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2D79FN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM463520 ((S)-3-(2-(Hydroxymethyl)pyrrolidin-1-yl)-2-phenylq...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2D79FN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM463521 (3-(3-Methylmorpholino)-2-phenylquinoxaline-6-carbo...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2D79FN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM574782 ((S)-3-(2-Methylpyrrolidin-1-yl)-2-phenylquinoxalin...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2D79FN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM574782 ((S)-3-(2-Methylpyrrolidin-1-yl)-2-phenylquinoxalin...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2D79FN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM463485 (2-(4-Fluorophenyl)-3-(isopropyl(methyl)amino)quino...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | Purchase MCE PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2D79FN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM463486 (3-(Isopropyl(methyl)amino)-2-(4-methoxyphenyl)quin...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2D79FN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM463487 ((R)-2-Phenyl-3-(2-(trifluoromethyl)pyrrolidin-1-yl...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2D79FN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM463523 ((R)-3-(Methyl(1-phenylethyl)amino)-2-phenylquinoxa...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2D79FN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM463524 ((S)-3-(Methyl(1-phenylethyl)amino)-2-phenylquinoxa...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2D79FN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM463525 ((R)-3-(sec-Butyl(methyl)amino)-2-phenylquinoxaline...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2D79FN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM463488 (3-(6-Methoxy-3,4-dihydroquinolin-1(2H)-yl)-2-pheny...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2D79FN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM463526 (3-(Indolin-1-yl)-2-phenylquinoxaline-6-carboxylic ...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2D79FN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM463527 (3-(2,3-Dihydrobenzo[b][1,4]oxazin-4-yl)-2-phenylqu...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2D79FN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM463526 (3-(Indolin-1-yl)-2-phenylquinoxaline-6-carboxylic ...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2D79FN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM463489 (2-(3,4-Difluorophenyl)-3-(isopropyl(methyl)amino)q...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2D79FN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM463490 (2-(4-Chlorophenyl)-3-(isopropyl(methyl)amino)quino...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2D79FN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM463529 (3-(Isopropyl(methyl)amino)-2-(3-methoxyphenyl)quin...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2D79FN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM463530 (2-(3-Fluorophenyl)-3-(isopropyl(methyl)amino)quino...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2D79FN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM463531 (2-(2-Fluorophenyl)-3-(isopropyl(methyl)amino)quino...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2D79FN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM463491 (3-(Cyclopentyl(methyl)amino)-2-phenylquinoxaline-6...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2D79FN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM574830 (3-(Isopropyl(methyl)amino)-2-(4-methoxyphenyl)quin...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2D79FN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM463492 ((S)-2-(4-Fluorophenyl)-3-(2-methylpyrrolidin-1-yl)...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2D79FN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM574791 (Butyl 2-(4-fluorophenyl)-3-(piperidin-1-yl)quinoxa...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2D79FN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM463494 (3-(Azepan-1-yl)-2-(4-fluorophenyl)quinoxaline-6-ca...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2D79FN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM463495 (2-(Benzo[d][1,3]dioxol-5-yl)-3-(isopropyl(methyl)a...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2D79FN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM463496 (2-(4-Fluorophenyl)-3-(3-(methoxymethyl)piperidin-1...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2D79FN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM463497 (3-(3,3-Dimethylpiperidin-1-yl)-2-(4-fluorophenyl)q...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2D79FN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM463498 (2-(4-Fluorophenyl)-3-(3-methylpiperidin-1-yl)quino...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2D79FN2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM463499 (2-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-3-(isoprop...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2D79FN2 | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 79 total ) | Next | Last >> |